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Abstract Storing and transporting of urine samples for
doping analysis, as performed by the anti-doping organi-
zations associated with the World Anti-Doping Agency,
does not include a specific protocol for cooled transport
from the place of urine sampling to the doping laboratory,
although low cost cooling facilities can easily be made
available. As a result, microbial and thermal degradation of
the chemical substances in the urine may occur, which may
lead to false negative or false positive results in the sub-
sequent doping analysis. This scientifically and morally
unacceptable practice is still maintained in spite of publi-
cations demonstrating that immediate cooling is an
absolute requirement. Given the enormous societal conse-
quences of positive tests, the lack of a controllable chain of
custody during transport should be outlawed. This paper
proposes a simple method, based on immediate cooling and
cooled transport, which can easily be implemented in
developed countries at low cost.
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Introduction
Given the importance for the athlete of a correctly performed
doping analysis of his urine, anti-doping institutions and
laboratories carry the scientific and moral obligation of
applying the highest quality of work standards to make sure
that the results of the analysis are a correct representation of
the composition of the urine at the moment that it was taken
from the athlete’s body. Anti-doping laboratories work under
a strict set of quality rules approved by the World Anti-
Doping Agency (WADA). However, WADA has not pro-
vided the national anti-doping organizations (ADO) with a
strict protocol on how to handle the urine samples during
storage and transport from the doping control station (i.e., the
sampling site of the urine) to the doping laboratory, although
this forms an important part of the total chain of custody
(chronological documentation of the handling of the urine)
[1]. The WADA has given the responsibility for this part of the
chain to the national ADO. The WADA requirement for the
protocol developed and authorized by ADO is that identity,
integrity and safety of the urine sample must be guaranteed.
This discussion focuses on the microbiological aspects of
sampling, storage and transport of urine samples from the
doping collection station (International Standard for Testing
[1]) until the opening for analysis of the samples in the doping
laboratory, where other guidelines apply (International
Standard for Laboratories) [2]. This paper does not discuss the
problems of thermal degradation, which also can occur with
certain components present in urine samples [3, 4].
Urine as a rich source for microbial growth
The composition of human urine is very complex and
influenced by the food taken prior to sampling. In all cases,
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urine represents a rich nutrient source for the growth of
microorganisms. At a temperature between 5 and 40 C
and a modest pH (4.5–8.5) microorganisms can multiply
at very high rates with generation times as low as 30 min.
[5–7] As a result, a single bacterium can increase to 109
cells in 15 h.
In principle, urine in the bladder is sterile. It gets,
however, contaminated with bacteria when it leaves the
urinal tract and is collected in bottles, which are not ster-
ilized. Initial contaminations can be in the order of
104cells/ml and hence it would take less than 10 h to reach
109cells/ml and thus spoil the urine sample completely.
Laboratory experiments, using urine samples from a
number of individuals incubated at 20–30 C, have proven
that the described storage circumstances lead to significant
microbial contamination. In each of the samples, sub-
stantial contamination, i.e., spoiling of the sample, was
demonstrated within 16–24 h, as shown by visual and
microscopic inspection ([6, 7] and experiments performed
by one of the authors). In these cases also the pH had
risen.
It must be stressed that a large diversity of microor-
ganisms, bacteria, yeast and fungi can grow in urine. They
posses an even much larger array of biological systems,
including enzymes that can change the compounds present
in the urine [4, 8]. A large number of publications have
shown that specific enzymes can transform a multitude of
hormones, drugs, antibiotics and xenobiotics [4]. In
essence, it is close to impossible to predict exactly the
outcome of microbial degradation, transformation and even
new synthesis of complex compounds, such as steroids [8,
9]. This can lead to false-negative and even false-positive
doping tests [9]. Therefore, it is obvious that microbial
contaminated samples no longer represent the originally
sampled urine and hence had lost their integrity. They are
therefore not suitable anymore for further analysis. Indeed,
it is unthinkable that any medical laboratory would ever
accept contaminated urine samples for analysis.
The inescapable conclusion is that to maintain the
integrity of urine samples, microbial growth should be
inhibited. A recent literature study, financed by WADA,
by Tsivou et al. [4] gives an excellent overview of dif-
ferent options. The conclusion of that study is that no
other method other than cooling and storing at B5 C is
suitable. However, to our great surprise, it is accepted as
a matter of fact in the same report that cooling or freezing
during transport is not always possible in the daily
practice of doping control. We challenge this fact as
totally out of date and therefore scientifically and morally
unacceptable (Table 1).
Table 1 The sampling, storage and transport of urine samples for doping control
Existing method Recommended method
1. Collect a minimum of 100 ml of urine at the doping
control station
1. Collect a minimum of 100 ml of urine at the doping
control station
2. Distribute 2/3 in bottle A and 1/3 in bottle B 2. Distribute 2/3 in bottle A and 1/3 in bottle B
3. Place in polystyrene insulating boxa 3A. Cool down in crushed ice to B5 C
3B. After cooling, place in polystyrene insulating box
and transfer to (portable) electrically powered cooler,
maintained at B5 C
4. Transport to home of DCO. Cooling is not
performeda
4. Transport in powered cooler at B5 C to home of
DCO
5. Place box in refrigerator of DCO at B5 C 5. Place box in refrigerator at B5 C or keep in cooler
B5 C
6. Transport box from DCO to ADO collection point;
cooling not performeda
6. Transport box from DCO to ADO collection point, at
B5 C, either in a cooler or in a refrigerated car
7. Store at ADO facilities. Cooling conditions unknown 7. Store at ADO facilities at B5 C
8. Transport of combined samples from ADO to doping
laboratory in a truck. No cooling performeda
8. Transport of combined samples from ADO to doping
laboratory at B5 C in a refrigerated truck
9. Receive in doping laboratory A-sample stored at
B5 C and B-sample frozen at -20 C
9. Receive in doping laboratory A-sample stored at
B5 C and B-sample frozen at -20 C
10. Analysis of sample A 10. Analysis at B5 days of total storage at B5 C
The information mentioned on the existing method was obtained from different athletes and from written information on the management of the
Dutch Anti-Doping Organization (ADO), which has stated that this method is representative for the majority of the World Anti-Doping Agency
(WADA) associated countries. Samples are taken by the drug control officer (DCO)
a The items are microbiologically unacceptable, since uncontrolled growth of unknown micro-organisms can occur and hence the integrity of the
sample can no longer be guaranteed
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The current practice of sampling
The current practice of sampling is summarized in first
column of Table 1. The steps in the first column indicated
by superscript a are microbiologically unacceptable, since
uncontrolled growth of unknown microorganisms may
occur. Hence the integrity of the sample can no longer be
guaranteed.
Especially the fact that the samples are not cooled
before placing in the polystyrene box (item 3) will result in
a long period of storing at temperatures favorable for
microbial growth, due to the high insulating capacity of the
polystyrene box itself. In addition, the time between leav-
ing the doping control station and the arrival at the home of
the drug control officer (DCO) is not standardized. If the
DCO has to visit and control different athletes, then this
time can go up to between 10 and 15 h. In the existing
procedure, the samples will be held at conditions very
favorable for microbial growth (item 4). In many countries/
laboratories, it is forbidden to put samples and food in the
same refrigerator. The ADO can supply the DCO with a
lockable refrigerator, which can also produce crushed ice.
This is not done at this moment (item 5). The conclusion is
that due to the lack of standardization in time and storage
temperature, the existing procedure [1] is not in agreement
with the principles of ‘‘chain of custody’’.
Cooling and transport of urine is easy to realize
Table 1 formulates in the second column a proposal of how
cooling and cooled transport may be realized in practice.
In any developed country, cooling of food is standard
and bound to strict rules. A complete transport infrastruc-
ture is available for cooled transport of small and big
volumes. For the individual traveler, electrical coolers are
available at low cost. Crushed ice can be obtained easily
and hence direct cooling of small urine samples and
transport at B5 C is practicable at low cost. It can be
calculated that to cool 100 ml urine from 35 to 5 C, about
40 g of ice is necessary. This means that 100 g of ice is
largely sufficient to cool the two samples.
Based on the experiences for storage of perishable food,
we advise that the total storage time (item 4–9) must not be
longer than 5 days (to be validated). If it is not possible to
do the analysis within this period, the A-sample must be
frozen until analysis.
Commercial manufacturers offer coolers with tempera-
ture indications and systems in which the alarms are
activated when the temperature of the box rises. A future
development can be to use temperature chips, which record
the temperature as a function of time and can be read after
opening the samples in the laboratory. This would be
completely in accordance with the principles of the ‘‘chain
of custody’’.
Control of microbial growth
It is of utmost importance that urine samples are checked
for microbial growth when they are opened in the labora-
tory. Often, this is only done by visual inspection of the
sample, which is inaccurate and subjective. In microbiol-
ogy, a number of methods are available and in use, for
example based on turbidity, and a variety of highly sensi-
tive staining techniques with particle counting, which can
easily be implemented in the laboratory. Standard
microscopy of stained samples can easily detect the growth
of microorganisms at a level that is at least 100 times more
sensitive than by direct visual inspection, whilst the sen-
sitivity can easily be further increased by filtering.
Validation
In the existing method, the temperatures and the storage
and transport times of the samples are not recorded, and
especially not standardized. Therefore, in the current
method/practice, every basis for validation and authoriza-
tion as required by WADA is lacking,
If the newly proposed method is followed, validation
would be straightforward, because the urine sample would
be maintained at a temperature of B5 C for a maximum of
5 days. For validation, a large number of fresh urine samples
can be monitored for growth and/or activity of microor-
ganisms at this temperature as a function of time. The period,
during which the number of microorganisms did not
increase in number significantly, would set the maximum
storage time of the samples from a microbiological point of
view. We realize that other (bio)chemical considerations
and data may reduce the acceptable time even further. If it is
not possible to do the analysis within the validated period,
the A-sample must be frozen until analysis. The proposed
method is well in accordance with good laboratory practice
[10], whilst the existing method is not.
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